2015年1.1至今天（3.26）欧盟DMF新注册的药物

佳佳妹 · 发表于 2015-3-26 14:01:27

本帖最后由佳佳妹于 2015-3-26 14:02 编辑

2015年1.1至今天（3.26）欧盟DMF新注册的药物共12条来源：药智网欧盟药品注册数据库http://db.yaozh.com/epyp/list.php

商标名	活性组分	通用名称	上市许可持有人	查看
Cerdelga	eliglustat	eliglustat	Genzyme Europe BV	查看
Clopidogrel ratiopharm	clopidogrel hydrogen sulphate	clopidogrel	Teva Pharma B.V.	查看
Cosentyx	secukinumab	secukinumab	Novartis Europharm Ltd	查看
Exviera	dasabuvir sodium	dasabuvir	AbbVie Ltd	查看
Holoclar	ex vivo expanded autologous human corneal epithelial cells containing stem cells	ex vivo expanded autologous human corneal epithelial cells containing stem cells	Chiesi Farmaceutici S.p.A.	查看
Ofev	nintedanib	nintedanib	Boehringer Ingelheim International GmbH	查看
Otezla	apremilast	apremilast	Celgene Europe Limited	查看
Rasagiline ratiopharm	rasagiline	rasagiline	Teva B.V.	查看
Senshio	ospemifene	ospemifene	Shionogi Limited	查看
Viekirax	ombitasvir / paritaprevir / ritonavir	ombitasvir / paritaprevir / ritonavir	AbbVie Ltd	查看
Xydalba	dalbavancin hcl	dalbavancin	Durata Therapeutics International B.V.	查看
Zontivity	vorapaxar sulfate	vorapaxar	Merck Sharp & Dohme Limited	查看

佳佳妹 · 发表于 2015-3-26 14:41:11

本帖最后由佳佳妹于 2015-3-26 14:45 编辑

产品编号	EMEA/H/C/003724
商标名	Cerdelga
通用名称	eliglustat
活性组分	eliglustat
ATC编码	A16AX1
适应症	Cerdelga is indicated for the long-term treatment of adult patients with Gaucher disease type 1 (GD1), who are CYP2D6 poor metabolisers (PMs), intermediate metabolisers (IMs) or extensive metabolisers (EMs).
孤儿药	yes
通用名药	no
上市许可持有人	Genzyme Europe BV
状态	授权
授权日期	2015-01-09
版本	0
条件批准	no
特殊情况	no
生物仿制品	no
详情参见	查看

佳佳妹 · 发表于 2015-3-26 14:41:43

本帖最后由佳佳妹于 2015-3-26 14:46 编辑

[size=13.333333969116211px]

产品编号	EMEA/H/C/004006
商标名	Clopidogrel ratiopharm
通用名称	clopidogrel
活性组分	clopidogrel hydrogen sulphate
ATC编码	B01AC0
适应症	Prevention of atherothrombotic eventsClopidogrel is indicated in: Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. Adult patients suffering from acute coronary syndrome: Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy. Prevention of atherothrombotic and thromboembolic events in atrial fibrillationIn adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.
孤儿药	no
通用名药	yes
上市许可持有人	Teva Pharma B.V.
状态	授权
授权日期	2015-02-19
版本	0
条件批准	no
特殊情况	no
生物仿制品	no
详情参见	查看

佳佳妹 · 发表于 2015-3-26 14:46:07

产品编号	EMEA/H/C/003729
商标名	Cosentyx
通用名称	secukinumab
活性组分	secukinumab
ATC编码	L04AC1
适应症	Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.
孤儿药	no
通用名药	no
上市许可持有人	Novartis Europharm Ltd
状态	授权
授权日期	2015-01-15
版本	0
条件批准	no
特殊情况	no
生物仿制品	no
详情参见	查看

tan1990 · 发表于 2015-3-26 14:50:50

筛选出来的，欧盟上市药品，有一定价值

天之羽翼 · 发表于 2015-3-26 14:53:43

没有做研发这块，但还是要了解下国际动向！！

我是可爱多多 · 发表于 2015-3-26 14:55:24

这些也收录到你们的数据库中了？

佳佳妹 · 发表于 2015-3-26 16:02:18

我是可爱多多发表于 2015-3-26 14:55
这些也收录到你们的数据库中了？

是滴，快来查

我是可爱多多 · 发表于 2015-3-26 17:27:03

佳佳妹发表于 2015-3-26 16:02
是滴，快来查

目前是免费的吗